The relation between pathological complete response and clinical outcome in patients with rectal cancer

Hepato-Gastroenterology

Volumn 60, Issue 126, 2013, Pages 1365-1370

  Tural, Deniz ^a   Selcukbiricik, Fatih ^a   Oz̈türk, Mehmet Akif ^a   Yildiz, Özcan ^a   Turna, Hande ^a   Erdamar, Sibel ^a   Buÿük̈unal, Evin ^a   Serdeņgecti, Suheyla ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Carcinoembryonic antigen; Chemoradiotherapy; Pathology; Rectal neoplasms

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LIVER FUNCTION; LOCAL RECURRENCE FREE SURVIVAL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATHOLOGICAL COMPLETE RESPONSE; PREOPERATIVE TREATMENT; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION DOSE; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CANCER; RECTUM CARCINOMA; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

ADULT; AGED; CARCINOEMBRYONIC ANTIGEN; CHEMORADIOTHERAPY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM STAGING; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 84885733604     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge13138     Document Type: Article

References (34)

1. Sauer R, Becker H, Hohenberger W, et al.: German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351:1731-1740.
2. Bosset JF, Collette L, Calais G, et al.: Chemotherapy with preoperative radiotherapy in rectal cancer. EORTC Radiotherapy Group Trial 22921. N Engl J Med 2006; 355:1114-1123. (Pubitemid 44394918)
3. Das P, Skibber JM, Rodriguez-Bigas MA, et al.: Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer 2007; 109:1750-1755. (Pubitemid 46668536)
4. de Campos-Lobato LF, Stocchi L, da Luz Moreira A, et al.: Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence. Ann Surg Oncol 2011; 18:1590-1598.
5. Moureau-Zabotto L, Farnault B, de Chaisemartin C, et al.: Predictive factors of tumor response after neoadjuvant chemoradiation for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2011; 80:483-491.
6. Sanghera P, Wong DW, McConkey CC, Geh JI, Hartley A: Chemoradiotherapy for rectal cancer: an updated analysis of factors affecting pathological response. Clin Oncol (R Coll Radiol) 2008; 20:176-183.
7. Ciccocioppo A, Stephens JH, Hewett PJ, Rieger NA: Complete pathologic response after preoperative rectal cancer chemoradiotherapy. ANZ J Surg 2009; 79:481-484.
8. Edge SB, Byrd DR, Compton CC, et al.: American Joint Committee on Cancer staging manual. 6th ed. Philadelphia: Springer; 2002.p. 173-200.
9. Bosset JF, Calais G, Mineur L, et al.: Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results - EORTC 22921. J Clin Oncol 2005; 23:5620-5627.
10. Gérard JP, Conroy T, Bonnetain F, et al.: Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006; 24:4620-4625. (Pubitemid 46630960)
11. Roh MS, Colangelo LH, O'Connell MJ, et al.: Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 2009; 27:5124-5130.
12. Kao PS, Chang SC, Wang LW, et al.: The impact of preoperative chemoradiotherapy on advanced low rectal cancer. J Surg Oncol 2010; 102:771-777.
13. Park HC, Janjan NA, Mendoza TR, et al.: Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 2009; 75:775-781.
14. Yoon SM, Kim DY, Kim TH, et al.: Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2007; 69:1167-1172. (Pubitemid 47625840)
15. Lin AY, Wong WD, Shia J, et al.: Predictive clinicopathologic factors for limited response of T3 rectal cancer to combined modality therapy. Int J Colorectal Dis 2008; 23:243-249.
16. Suzuki T, Sadahiro S, Fukasawa M, et al.: Predictive factors of tumor shrinkage and histological regression in patients who received preoperative radiotherapy for rectal cancer. Jpn J Clin Oncol 2004; 34:740-746. (Pubitemid 41615271)
17. Park YA, Sohn SK, Seong J, et al.: Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer. J Surg Oncol 2006; 93:145-150. (Pubitemid 43235261)
18. Capirci C, Valentini V, Cionini L, et al.: Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. Radiat Oncol Biol Phys 2008; 72:99-107.
19. Bujko K, Michalski W, Kepka L, et al.: Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: an analysis of outcomes in a randomized trial. Int J Radiat Oncol Biol Phys 2007; 67:369-377. (Pubitemid 46127610)
20. Stipa F, Chessin DB, Shia J, et al.: A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography. Ann Surg Oncol 2006; 13:1047-1053. (Pubitemid 44337963)
21. Bujko K, Michalski W, Kepka L, et al.: Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 2004; 72:15-24. (Pubitemid 38952855)
22. Onaitis MW, Noone RB, Fields R, et al.: Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival. Ann Surg Oncol 2001; 10:801-806. (Pubitemid 34003329)
23. Pucciarelii S, Toppan P, Friso ML, et al.: Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome. Dis Colon Rectum 2004; 47:1798-1807. (Pubitemid 40064422)
24. Janjan NA, Crane C, Feig BW, et al.: Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer.Am J Clin Oncol 2001; 24:107-112. (Pubitemid 32323343)
25. Willett CG, Warland G, Coen J, Shellito PC, Compton CC: Rectal cancer: the influence of tumor proliferation on response to preoperative irradiation. Int J Radiat Oncol Biol Phys 1995; 32:57-61.
26. Perez RO, São Julião GP, Habr-Gama A, et al.: The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer. Dis Colon Rectum 2009; 52:1137-1143.
27. Kim JS, Kim JM, Li S, et al.: Epidermal growth factor receptor as a predictor of tumor downstaging in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy. Int J Radiat Oncol Biol Phys 2006; 66:195-200. (Pubitemid 44175651)
28. Spindler KL, Nielsen JN, Lindebjerg J, Brandslund I, Jakobsen A: Prediction of response to chemoradiation in rectal cancer by a gene polymorphism in the epidermal growth factor receptor promoter region. Int J Radiat Oncol Biol Phys 2006; 66:500-504. (Pubitemid 44332722)
29. Lopez-Crapez E, Bibeau F, Thézenas S, et al.: p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis. Br J Cancer 2005; 92:2114-2121. (Pubitemid 40966245)
30. Lin LC, Lee HH, Hwang WS, et al.: p53 and p27 as predictors of clinical outcome for rectal-cancer patients receiving neoadjuvant therapy. Surg Oncol 2006; 15:211-216.
31. Debucquoy A, Goethals L, Libbrecht L, et al.: Molecular and clinico-pathological markers in rectal cancer: a tissue microarray study. Int J Colorectal Dis 2009; 24:129-138.
32. Kim IJ, Lim SB, Kang HC, et al.: Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer. Dis Colon Rectum 2007; 50:1342-1353. (Pubitemid 47472394)
33. Neuman HB, Elkin EB, Guillem JG, et al.: Treatment for patients with rectal cancer and a clinical complete response to neoadjuvant therapy: a decision analysis. Dis Colon Rectum 2009; 52:863-871.
34. Zlobec I, Steele R, Nigam N, Compton CC: A predictive model of rectal tumor response to preoperative radiotherapy using classification and regression tree methods. Clin Cancer Res 2005;11:5440-5443. (Pubitemid 41060819)